Wird geladen...
A cell-free antibody engineering platform rapidly generates SARS-CoV-2 neutralizing antibodies
Antibody engineering technologies face increasing demands for speed, reliability and scale. We developed CeVICA, a cell-free antibody engineering platform that integrates a novel generation method and design for camelid heavy-chain antibody VHH domain-based synthetic libraries, optimized in vitro se...
Gespeichert in:
| Veröffentlicht in: | bioRxiv |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Cold Spring Harbor Laboratory
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7605568/ https://ncbi.nlm.nih.gov/pubmed/33140055 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.10.29.361287 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|